APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neuroimaging Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Neuroimaging Software Market Outlook and Growth Opportunities 2026

Report ID 17419689041 January 2026193 pages

Choose your research edition.

Industry ResearchNeuroimaging Software Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuroimaging Software Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Neuroimaging Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuroimaging Software Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuroimaging Software Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Neuroimaging Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Neuroimaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neuroimaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neuroimaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Neuroimaging Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Neuroimaging Software market include IXICO, QMENTA, Cortechs.ai, Quantib, Brainomix, Qure.AI, Imaging Biometrics, LLC and A.I. Analysis, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Neuroimaging Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neuroimaging Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neuroimaging Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Neuroimaging Software market.

Neuroimaging Software Segment by Company

IXICO

QMENTA

Cortechs.ai

Quantib

Brainomix

Qure.AI

Imaging Biometrics, LLC

A.I. Analysis, Inc

Neuroimaging Software Segment by Type

Cloud-based

On Premise

Neuroimaging Software Segment by Application

Hospitals and Clinics

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Neuroimaging Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neuroimaging Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Neuroimaging Software key companies, revenue, market share, and recent developments.

3. To split the Neuroimaging Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Neuroimaging Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neuroimaging Software significant trends, drivers, influence factors in global and regions.

6. To analyze Neuroimaging Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroimaging Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuroimaging Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroimaging Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neuroimaging Software industry.

Chapter 3: Detailed analysis of Neuroimaging Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Neuroimaging Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Neuroimaging Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neuroimaging Software Industry Trends Table 2. Neuroimaging Software Industry Drivers Table 3. Neuroimaging Software Industry Opportunities and Challenges Table 4. Neuroimaging Software Industry Restraints Table 5. Global Neuroimaging Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neuroimaging Software Revenue Share by Company (2021-2026) Table 7. Global Neuroimaging Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Neuroimaging Software Key Company Manufacturing Base & Headquarters Table 9. Global Neuroimaging Software Company, Product Type & Application Table 10. Global Neuroimaging Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Neuroimaging Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On Premise Table 16. Global Neuroimaging Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Neuroimaging Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Neuroimaging Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Neuroimaging Software Sales Value Share by Type (2021-2026) Table 20. Global Neuroimaging Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals and Clinics Table 22. Significant Companies of Diagnostic Imaging Centers Table 23. Significant Companies of Ambulatory Surgical Centers Table 24. Global Neuroimaging Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Neuroimaging Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Neuroimaging Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Neuroimaging Software Sales Value Share by Application (2021-2026) Table 28. Global Neuroimaging Software Sales Value Share by Application (2027-2032) Table 29. Global Neuroimaging Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Neuroimaging Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Neuroimaging Software Sales Value Share by Region (2021-2026) Table 32. Global Neuroimaging Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Neuroimaging Software Sales Value Share by Region (2027-2032) Table 34. Global Neuroimaging Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Neuroimaging Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Neuroimaging Software Sales Value Market Share by Country (2021-2026) Table 37. Global Neuroimaging Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Neuroimaging Software Sales Value Market Share by Country (2027-2032) Table 39. IXICO Company Information Table 40. IXICO Business Overview Table 41. IXICO Neuroimaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. IXICO Neuroimaging Software Product Portfolio Table 43. IXICO Recent Development Table 44. QMENTA Company Information Table 45. QMENTA Business Overview Table 46. QMENTA Neuroimaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. QMENTA Neuroimaging Software Product Portfolio Table 48. QMENTA Recent Development Table 49. Cortechs.ai Company Information Table 50. Cortechs.ai Business Overview Table 51. Cortechs.ai Neuroimaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Cortechs.ai Neuroimaging Software Product Portfolio Table 53. Cortechs.ai Recent Development Table 54. Quantib Company Information Table 55. Quantib Business Overview Table 56. Quantib Neuroimaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Quantib Neuroimaging Software Product Portfolio Table 58. Quantib Recent Development Table 59. Brainomix Company Information Table 60. Brainomix Business Overview Table 61. Brainomix Neuroimaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Brainomix Neuroimaging Software Product Portfolio Table 63. Brainomix Recent Development Table 64. Qure.AI Company Information Table 65. Qure.AI Business Overview Table 66. Qure.AI Neuroimaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Qure.AI Neuroimaging Software Product Portfolio Table 68. Qure.AI Recent Development Table 69. Imaging Biometrics, LLC Company Information Table 70. Imaging Biometrics, LLC Business Overview Table 71. Imaging Biometrics, LLC Neuroimaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Imaging Biometrics, LLC Neuroimaging Software Product Portfolio Table 73. Imaging Biometrics, LLC Recent Development Table 74. A.I. Analysis, Inc Company Information Table 75. A.I. Analysis, Inc Business Overview Table 76. A.I. Analysis, Inc Neuroimaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. A.I. Analysis, Inc Neuroimaging Software Product Portfolio Table 78. A.I. Analysis, Inc Recent Development Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Neuroimaging Software Product Image Figure 2. Global Neuroimaging Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuroimaging Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Neuroimaging Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On Premise Image Figure 9. Global Neuroimaging Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Neuroimaging Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Neuroimaging Software Sales Value Share by Type (2021-2032) Figure 12. Hospitals and Clinics Image Figure 13. Diagnostic Imaging Centers Image Figure 14. Ambulatory Surgical Centers Image Figure 15. Global Neuroimaging Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Neuroimaging Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Neuroimaging Software Sales Value Share by Application (2021-2032) Figure 18. Global Neuroimaging Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Neuroimaging Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Neuroimaging Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Neuroimaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Neuroimaging Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Neuroimaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Neuroimaging Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Neuroimaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Neuroimaging Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Neuroimaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Neuroimaging Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Neuroimaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Neuroimaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Neuroimaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Neuroimaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On Premise
Applications
  • Hospitals and Clinics
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
Companies covered
  • IXICO
  • QMENTA
  • Cortechs.ai
  • Quantib
  • Brainomix
  • Qure.AI
  • Imaging Biometrics, LLC
  • A.I. Analysis, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neuroimaging Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neuroimaging Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Neuroimaging Software Market Dynamics
  1. 2.1 Neuroimaging Software Industry Trends
  2. 2.2 Neuroimaging Software Industry Drivers
  3. 2.3 Neuroimaging Software Industry Opportunities and Challenges
  4. 2.4 Neuroimaging Software Industry Restraints
3 Neuroimaging Software Market by Company
  1. 3.1 Global Neuroimaging Software Company Revenue Ranking in 2025
  2. 3.2 Global Neuroimaging Software Revenue by Company (2021-2026)
  3. 3.3 Global Neuroimaging Software Company Ranking (2024-2026)
  4. 3.4 Global Neuroimaging Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Neuroimaging Software Company Product Type and Application
  6. 3.6 Global Neuroimaging Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Neuroimaging Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Neuroimaging Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Neuroimaging Software Market by Type
  1. 4.1 Neuroimaging Software Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On Premise
  4. 4.2 Global Neuroimaging Software Sales Value by Type
  5. 4.2.1 Global Neuroimaging Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Neuroimaging Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Neuroimaging Software Sales Value Share by Type (2021-2032)
5 Neuroimaging Software Market by Application
  1. 5.1 Neuroimaging Software Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Diagnostic Imaging Centers
  4. 5.1.3 Ambulatory Surgical Centers
  5. 5.2 Global Neuroimaging Software Sales Value by Application
  6. 5.2.1 Global Neuroimaging Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neuroimaging Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Neuroimaging Software Sales Value Share by Application (2021-2032)
6 Neuroimaging Software Regional Value Analysis
  1. 6.1 Global Neuroimaging Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neuroimaging Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Neuroimaging Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Neuroimaging Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neuroimaging Software Sales Value (2021-2032)
  7. 6.3.2 North America Neuroimaging Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Neuroimaging Software Sales Value (2021-2032)
  10. 6.4.2 Europe Neuroimaging Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Neuroimaging Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Neuroimaging Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Neuroimaging Software Sales Value (2021-2032)
  16. 6.6.2 South America Neuroimaging Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Neuroimaging Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Neuroimaging Software Sales Value Share by Country, 2025 VS 2032
7 Neuroimaging Software Country-level Value Analysis
  1. 7.1 Global Neuroimaging Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neuroimaging Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Neuroimaging Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Neuroimaging Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Neuroimaging Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Neuroimaging Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Neuroimaging Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Neuroimaging Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Neuroimaging Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Neuroimaging Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Neuroimaging Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Neuroimaging Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Neuroimaging Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Neuroimaging Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Neuroimaging Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Neuroimaging Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Neuroimaging Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Neuroimaging Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Neuroimaging Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Neuroimaging Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Neuroimaging Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Neuroimaging Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Neuroimaging Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Neuroimaging Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Neuroimaging Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Neuroimaging Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Neuroimaging Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Neuroimaging Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Neuroimaging Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Neuroimaging Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Neuroimaging Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Neuroimaging Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Neuroimaging Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Neuroimaging Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IXICO
  2. 8.1.1 IXICO Company Information
  3. 8.1.2 IXICO Business Overview
  4. 8.1.3 IXICO Neuroimaging Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 IXICO Neuroimaging Software Product Portfolio
  6. 8.1.5 IXICO Recent Developments
  7. 8.2 QMENTA
  8. 8.2.1 QMENTA Company Information
  9. 8.2.2 QMENTA Business Overview
  10. 8.2.3 QMENTA Neuroimaging Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 QMENTA Neuroimaging Software Product Portfolio
  12. 8.2.5 QMENTA Recent Developments
  13. 8.3 Cortechs.ai
  14. 8.3.1 Cortechs.ai Company Information
  15. 8.3.2 Cortechs.ai Business Overview
  16. 8.3.3 Cortechs.ai Neuroimaging Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cortechs.ai Neuroimaging Software Product Portfolio
  18. 8.3.5 Cortechs.ai Recent Developments
  19. 8.4 Quantib
  20. 8.4.1 Quantib Company Information
  21. 8.4.2 Quantib Business Overview
  22. 8.4.3 Quantib Neuroimaging Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Quantib Neuroimaging Software Product Portfolio
  24. 8.4.5 Quantib Recent Developments
  25. 8.5 Brainomix
  26. 8.5.1 Brainomix Company Information
  27. 8.5.2 Brainomix Business Overview
  28. 8.5.3 Brainomix Neuroimaging Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Brainomix Neuroimaging Software Product Portfolio
  30. 8.5.5 Brainomix Recent Developments
  31. 8.6 Qure.AI
  32. 8.6.1 Qure.AI Company Information
  33. 8.6.2 Qure.AI Business Overview
  34. 8.6.3 Qure.AI Neuroimaging Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qure.AI Neuroimaging Software Product Portfolio
  36. 8.6.5 Qure.AI Recent Developments
  37. 8.7 Imaging Biometrics, LLC
  38. 8.7.1 Imaging Biometrics, LLC Company Information
  39. 8.7.2 Imaging Biometrics, LLC Business Overview
  40. 8.7.3 Imaging Biometrics, LLC Neuroimaging Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Imaging Biometrics, LLC Neuroimaging Software Product Portfolio
  42. 8.7.5 Imaging Biometrics, LLC Recent Developments
  43. 8.8 A.I. Analysis, Inc
  44. 8.8.1 A.I. Analysis, Inc Company Information
  45. 8.8.2 A.I. Analysis, Inc Business Overview
  46. 8.8.3 A.I. Analysis, Inc Neuroimaging Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 A.I. Analysis, Inc Neuroimaging Software Product Portfolio
  48. 8.8.5 A.I. Analysis, Inc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst